Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00926601
First received: June 20, 2009
Last updated: June 13, 2012
Last verified: June 2012
  Purpose

Several case report showed that the co-infection of Mycoplasma pneumoniae in patients with pulmonary tuberculosis. The aim of this study is to elucidate the prevalence and its clinical significance of co-infection of Mycoplasma pneumonia in patients with newly diagnosed pulmonary tuberculosis.


Condition
Mycoplasma Pneumonia
Pulmonary Tuberculosis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Biospecimen Retention:   Samples Without DNA

Sera of TB patient


Estimated Enrollment: 100
Study Start Date: June 2009
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pulmonary tuberculosis

Criteria

Inclusion Criteria:

  • Bacteriologically or clinically diagnosed pulmonary TB
  • Older than 17years

Exclusion Criteria:

  • HIV positive
  • Immune-compromized
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00926601

Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Jae-Joon Yim, MD Seoul National University Hospital
  More Information

No publications provided

Responsible Party: Jae-Joon Yim / Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT00926601     History of Changes
Other Study ID Numbers: H-0906-006-281
Study First Received: June 20, 2009
Last Updated: June 13, 2012
Health Authority: Republic of Korea: Institutional Review Board

Additional relevant MeSH terms:
Coinfection
Mycoplasma Infections
Pleuropneumonia
Pneumonia
Pneumonia, Mycoplasma
Tuberculosis
Tuberculosis, Pulmonary
Actinomycetales Infections
Bacterial Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Infection
Lung Diseases
Mycobacterium Infections
Mycoplasmatales Infections
Parasitic Diseases
Pleural Diseases
Pleurisy
Pneumonia, Bacterial
Respiratory Tract Diseases
Respiratory Tract Infections
Virus Diseases

ClinicalTrials.gov processed this record on November 25, 2014